|
US 12,006,349 B2 |
|
| Peptides and combination of peptides for use in immunotherapy against various tumors |
| Andrea Mahr, Tuebingen (DE); Toni Weinschenk, Aichwald (DE); Oliver Schoor, Tuebingen (DE); Jens Fritsche, Dusslingen (DE); Harpreet Singh, Munich (DE); and Lea Stevermann, Aachen (DE) |
| Assigned to Immatics Biotechnologies GmbH, (DE) |
| Filed by Immatics Biotechnologies GmbH, Tuebingen (DE) |
| Filed on Aug. 6, 2021, as Appl. No. 17/396,323. |
| Application 17/396,323 is a continuation of application No. 17/179,074, filed on Feb. 18, 2021. |
| Application 17/179,074 is a continuation of application No. 16/900,542, filed on Jun. 12, 2020, granted, now 10,947,293, issued on Mar. 16, 2021. |
| Application 16/900,542 is a continuation of application No. 16/055,796, filed on Aug. 6, 2018, granted, now 10,934,338, issued on Mar. 2, 2021. |
| Application 16/055,796 is a continuation of application No. 15/082,948, filed on Mar. 28, 2016, granted, now 10,081,664, issued on Sep. 25, 2018. |
| Claims priority of provisional application 62/139,189, filed on Mar. 27, 2015. |
| Claims priority of application No. 1505305 (GB), filed on Mar. 27, 2015. |
| Prior Publication US 2022/0017595 A1, Jan. 20, 2022 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. A61K 38/00 (2006.01); A01N 37/46 (2006.01); A61K 38/06 (2006.01); A61K 38/08 (2019.01); A61K 38/17 (2006.01); A61K 39/00 (2006.01); A61K 45/06 (2006.01); C07K 7/02 (2006.01); C07K 7/06 (2006.01); C07K 14/00 (2006.01); C07K 14/47 (2006.01); C07K 14/725 (2006.01); C07K 14/74 (2006.01); C07K 16/18 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); C12N 5/0783 (2010.01); C12N 9/64 (2006.01); C12Q 1/6886 (2018.01); G01N 33/50 (2006.01); G01N 33/566 (2006.01); G01N 33/569 (2006.01) |